PRO-DEX, INC. Form DEFC14A: Definitive proxy statement in a contested solicitation
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2012-12-20: Form DEFC14A; Description DEFC14A; Document d430920ddefc14a.htm.
- 2012-12-20: Form DEFC14A; Description PROXY STATEMENT; Document aopilp-defc14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2012-12-20 | DEFC14A | DEFC14A | d430920ddefc14a.htm | |
| 2012-12-20 | DEFC14A | PROXY STATEMENT | aopilp-defc14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |